Identification of ALK as a major familial neuroblastoma predisposition gene
…, R Sennett, JE Lynch, P Perri, G Laureys… - Nature, 2008 - nature.com
Neuroblastoma is a childhood cancer that can be inherited, but the genetic aetiology is largely
unknown. Here we show that germline mutations in the anaplastic lymphoma kinase (ALK…
unknown. Here we show that germline mutations in the anaplastic lymphoma kinase (ALK…
[HTML][HTML] Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma
…, J Bökkerink, M Egeler, G Laureys… - … England Journal of …, 1996 - Mass Medical Soc
Background Neuroblastoma is a childhood tumor derived from cells of the neural crest, with
a widely variable outcome. Differences in the behavior and prognosis of the tumor suggest …
a widely variable outcome. Differences in the behavior and prognosis of the tumor suggest …
Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification
…, T Van Maerken, A De Paepe, G Laureys… - Clinical cancer …, 2010 - AACR
Purpose: Activating mutations of the anaplastic lymphoma kinase (ALK) were recently
described in neuroblastoma. We carried out a meta-analysis of 709 neuroblastoma tumors to …
described in neuroblastoma. We carried out a meta-analysis of 709 neuroblastoma tumors to …
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international …
…, V Castel, I Yaniv, V Papadakis, G Laureys… - The lancet …, 2017 - thelancet.com
Background High-dose chemotherapy with haemopoietic stem-cell rescue improves event-free
survival in patients with high-risk neuroblastoma; however, which regimen has the …
survival in patients with high-risk neuroblastoma; however, which regimen has the …
[HTML][HTML] Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes
…, Y Benoit, M Renard, AD Paepe, G Laureys… - Genome biology, 2006 - Springer
Background Neuroblastoma tumor cells are assumed to originate from primitive neuroblasts
giving rise to the sympathetic nervous system. Because these precursor cells are not …
giving rise to the sympathetic nervous system. Because these precursor cells are not …
Unequivocal delineation of clinicogenetic subgroups and development of a new model for improved outcome prediction in neuroblastoma
…, S De Bie, A De Paepe, G Laureys… - Journal of Clinical …, 2005 - ascopubs.org
Purpose Neuroblastoma is a genetically heterogeneous pediatric tumor with a remarkably
variable clinical behavior ranging from widely disseminated disease to spontaneous …
variable clinical behavior ranging from widely disseminated disease to spontaneous …
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
…, P McGrady, WB London, G Laureys… - The lancet …, 2009 - thelancet.com
Background More accurate prognostic assessment of patients with neuroblastoma is required
to better inform the choice of risk-related therapy. The aim of this study is to develop and …
to better inform the choice of risk-related therapy. The aim of this study is to develop and …
[HTML][HTML] Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay
…, F Speleman, V Combaret, J Lunec, G Laureys… - Modern …, 2002 - nature.com
Amplification of the proto-oncogene MYCN is a strong adverse prognostic factor in neuroblastoma
patients in all tumor stages. The status of the MYCN gene has become an important …
patients in all tumor stages. The status of the MYCN gene has become an important …
Randomized trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European …
…, P Brock, I Yaniv, V Castel, G Laureys… - Journal of Clinical …, 2010 - ascopubs.org
Purpose To reduce the incidence of febrile neutropenia during rapid COJEC (cisplatin,
vincristine, carboplatin, etoposide, and cyclophosphamide given in a rapid delivery schedule) …
vincristine, carboplatin, etoposide, and cyclophosphamide given in a rapid delivery schedule) …
The expression and role of CXC chemokines in colorectal cancer
H Verbeke, S Struyf, G Laureys… - Cytokine & growth factor …, 2011 - Elsevier
Cancer is a life-threatening disease world-wide and colorectal cancer is the second common
cause of cancer mortality. The interaction between tumor cells and stromal cells plays a …
cause of cancer mortality. The interaction between tumor cells and stromal cells plays a …